No OS Benefit for Adjuvant Treatment of Stage III Melanoma No OS Benefit for Adjuvant Treatment of Stage III Melanoma

Guidelines recommending adjuvant treatment for stage III melanoma should be revisited, say researchers reporting a review of data that found no overall survival benefit.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Hematology-Oncology News Source Type: news